【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Rheumatoid – Inflammatory Diseases Markers Tests Overview 10
3 Products under Development 11
3.1 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products by Stage of Development 11
3.2 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products by Segment 12
3.3 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products by Territory 13
3.4 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products by Regulatory Path 14
3.5 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products by Estimated Approval Date 15
4 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products under Development by Companies 16
4.1 Rheumatoid – Inflammatory Diseases Markers Tests Companies – Pipeline Products by Stage of Development 16
4.2 Rheumatoid – Inflammatory Diseases Markers Tests – Pipeline Products by Stage of Development 18
5 Rheumatoid – Inflammatory Diseases Markers Tests Companies and Product Overview 21
5.1 Abcodia Ltd. Company Overview 21
5.1.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Albert-Ludwigs-Universitat Freiburg Company Overview 23
5.2.1 Albert-Ludwigs-Universitat Freiburg Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Analyticon Biotechnologies AG Company Overview 24
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 AnaMar AB Company Overview 26
5.4.1 AnaMar AB Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Bayerische Patentallianz GmbH Company Overview 27
5.5.1 Bayerische Patentallianz GmbH Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Beckman Coulter, Inc. Company Overview 28
5.6.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 BioSIMS Company Overview 42
5.7.1 BioSIMS Pipeline Products & Ongoing Clinical Trials Overview 42
5.8 CD Diagnostics, Inc. Company Overview 43
5.8.1 CD Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.9 Chronix Biomedical, Inc. Company Overview 45
5.9.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.10 Consejo Superior de Investigaciones Cientificas Company Overview 47
5.10.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 47
5.11 Crescendo Bioscience, Inc. Company Overview 49
5.11.1 Crescendo Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 DIESSE Diagnostica Senese S.p.A. Company Overview 50
5.12.1 DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 DSX Therapeutics Company Overview 51
5.13.1 DSX Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Fundacio Clinic per a la Recerca Biomedica Company Overview 52
5.14.1 Fundacio Clinic per a la Recerca Biomedica Pipeline Products & Ongoing Clinical Trials Overview 52
5.15 Genalyte, Inc. Company Overview 55
5.15.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 GeneNews Limited Company Overview 56
5.16.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Ghent University Company Overview 58
5.17.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 58
5.18 Ignyta, Inc. Company Overview 59
5.18.1 Ignyta, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.19 Institut National de la Sante et de la Recherche Medicale Company Overview 63
5.19.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 63
5.20 KineMed, Inc. Company Overview 66
5.20.1 KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.21 Louisville Bioscience, Inc. Company Overview 67
5.21.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.22 Myriad Genetics, Inc. Company Overview 68
5.22.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.23 Proplex Technologies, Llc Company Overview 70
5.23.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 70
5.24 Protagen AG Company Overview 72
5.24.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 72
5.25 Selventa Company Overview 74
5.25.1 Selventa Pipeline Products & Ongoing Clinical Trials Overview 74
5.26 Siemens Healthcare Diagnostics Inc. Company Overview 75
5.26.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.27 Singulex, Inc. Company Overview 79
5.27.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.28 SomaLogic, Inc. Company Overview 80
5.28.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.29 SQI Diagnostics Inc. Company Overview 81
5.29.1 SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.30 The Binding Site Group Ltd. Company Overview 83
5.30.1 The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83
5.31 The Johns Hopkins University Company Overview 84
5.31.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 84
5.32 Thermo Fisher Scientific Inc. Company Overview 86
5.32.1 Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.33 Toscana Biomarkers Srl Company Overview 89
5.33.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview 89
5.34 University of Aberdeen Company Overview 90
5.34.1 University of Aberdeen Pipeline Products & Ongoing Clinical Trials Overview 90
5.35 University of Manchester Company Overview 91
5.35.1 University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 91
5.36 University of Missouri Company Overview 92
5.36.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 92
5.37 University of Oxford Company Overview 93
5.37.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 93
5.38 University of Rochester Company Overview 95
5.38.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 95
5.39 University of Warwick Company Overview 96
5.39.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 96
5.40 University Rovira i Virgili Company Overview 98
5.40.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 98
6 Rheumatoid – Inflammatory Diseases Markers Tests- Recent Developments 99
7 Appendix 111
7.1 Methodology 111
7.2 About GlobalData 113
7.3 Contact Us 114
7.4 Disclaimer 114
【レポート販売概要】
■ タイトル：世界におけるリウマチ性炎症性疾患マーカー検査製品のパイプライン動向2015■ 英文：Rheumatoid - Inflammatory Diseases Markers Tests - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0088EPD
■ 調査対象地域：グローバル
- 世界のフリート管理システム市場動向（2012-2016）TechNavio's analysts forecast the Global Fleet Management System market to grow at a CAGR of 26.66 percent over the period 2012-2016. One of the key factors contributing to this market growth is the expansion of fleet size of commercial vehicles. The Global Fleet Management System market has also been witnessing an increasing number of in-vehicle technologies. However, the increasing operating cos …
- 石油・ガス産業用ポンプの世界市場2016-2020：渦巻きポンプ、容積式ポンプAbout Pumps for the Oil and Gas Industry The global oil and gas industry remains volatile with high fluctuations in crude oil prices. This is directly impacting the demand for pumps from the industry, especially through depressed upstream investments in the current scenario of low crude oil prices. The current state of the pumps market in the oil and gas industry can be considered as significantly …
- モバイルコマース360（Mobile Commerce 360）Mobile commerce is exploding with applications and services driven by emerging technologies, use cases, and business models. M-commerce is quite different from traditional e-commerce as the ecosystem and value chain are more dynamic and are evolving in a different manner than e-commerce as a whole. Mobile Commerce 360 is an annual subscription service that provides research, analysis, and advisory …
- iPad in Healthcare: Quantitative Assessment and Qualitative AnalysisIn this report we analyze iPad in the marketplace including the threat of direct and indirect competition by applying Porter's 5-forced model. The model evaluates key factors including Supplier Power, Barriers to Entry, Buyer Power, and Threat of Substitutes. The report estimates the adoption of iPad by applying existing data to applicable mathematical models. It then presents the opportunities/ch …
- ヒマシ油と派生物の世界市場分析：製品別（セバシン酸、リシノール酸、ウンデシレン酸、キャスターワックス、脱水ひまし油）、用途別（潤滑剤、表面コーティング、バイオディーゼル、化粧品･医薬品、プラスチック･樹脂）、セグメント予測-2024The global castor oil and derivatives market is expected to reach USD 2.30 billion by 2024, according to a new report by Grand View Research, Inc. Rise in petrochemical prices coupled with growing end-use commercial activity and demand for the sustainable and renewable source is expected to compel the market growth over the next eight years. The market is estimated to witness a high growth owing t …
- 世界のSuncare市場：M&A動向（2014年4月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global suncare market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global suncare market throughout the month. Additionally, the report provides an overview of all the partnering …
- 世界のオイルシェール市場分析：Analyzing the Global Oil Shale MarketThe term oil shale generally refers to any sedimentary rock that contains solid bituminous materials (called kerogen) that are released as petroleum-like liquids when the rock is heated in the chemical process of pyrolysis. Oil shale was formed millions of years ago by deposition of silt and organic debris on lake beds and sea bottoms. Over long periods of time, heat and pressure transformed the m …
- インターベンショナルラジオロジー製品の世界市場予測（～2021）：種類別（ステント、カテーテル、IVCフィルター、アクセサリ）、手術種類別、用途別The interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%. This market is segmented based on type, procedure, application, and region. The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. Howe …
- 世界の無人航空機（UAV）市場動向2013-2023：地域別分析"The Global UAV Market 2013-2023 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an analysis of the top segments of UAV, expected to be in demand. It also investigates the top three expected UAV programs, in terms of demand in the key markets in each region.
- 連節バスの世界市場2017-2021About Articulated Bus Currently, the articulated bus market is in the growth stage and is witnessing a high adoption. Developed regions like Europe and North America are witnessing the adoption of articulated buses owing to the growing demand for high passenger capacity and emission control measures. In addition, articulated buses are gaining traction in emerging markets like India and China. The …
- 据置鉛蓄電池（SLA電池）の世界市場About SLA Batteries Lead-acid batteries are rechargeable batteries, which contain lead electrodes with diluted sulphuric acid that acts as an electrolyte. Lead-acid batteries used for stationary applications are known as SLA batteries. Each cell in a typical lead-acid battery generates approximately 2 volts. Although SLA batteries have very low energy-to-weight and energy-to-volume ratios, they ha …
- くる病治療の世界市場2019-2023About this market The growing awareness about vitamin D deficiency is one of the key factors expected to trigger market growth in the upcoming years. Rickets is often caused due to vitamin D deficiency in the body due to less exposure to the sun, dark skin, and the lack of vitamin D in the diet. Several programs are being initiated for creating public awareness about the health issues associated w …
- 輸送管理システム（TMS）の世界市場2017-2021About Transport Management System Transport management system (TMS) is a subsection of supply chain management relating to transportation operations. TMS provides a wide variety of functions to optimize and automate transport processes for shippers and logistics service provider. It includes planning, execution, financials (freight payment and cost allocation), and fleet management. Technavio’s an …
- マグネトロンの世界市場2016-2020：家電、通信用About Magnetron Magnetrons having the capability to achieve frequency agility (FA) in regard to radar operations are called frequency agile magnetrons. They can tune the output frequency of the radar with a speed that is sufficient to produce pulse-to-pulse frequency change. This changing frequency is greater than the amount required and allows the radar to effectively obtain decorrelation of adja …
- ビジュアルアナリティクスの世界市場予測（～2022年）The visual analytics market is expected to grow from USD 2.57 Billion in 2017 to USD 6.51 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 20.4%. The major growth drivers of the market include the rapid growth in volume and variety of business data, growing need for data-driven decision-making, and increasing demand for advanced analytics. The visual analytics market is segmented by sof …
